Formulations of a stable budesonide high-viscosity oral suspension, suitable for the treatment of eosiniphilic esophagitis, formulated with ingredients of well established medicinal use. The formulations constitute examples for the manufacture of a therapeutic product which is easily administered or self-administered, thereby ensuring the best patient compliance.